In this report, we show that the compound GSK2981278 is a highly potent and selective inverse agonist for RORγ that inhibits production of the Th17 signature cytokines in multiple in vitro cell-based assays, ex vivo human models and in an in vivo mouse model of psoriasis. Here, RORC is linked to psoriasis.